Company Profile

Neovasc Inc. is a Canada-based specialty medical device company. The Company develops, manufactures, and markets products for the cardiovascular marketplace. The Company is engaged in the development of minimally invasive therapies in cardiovascular care: refractory angina and mitral valve regurgitation. Its products include the Neovasc Reducer (Reducer), for the treatment of refractory angina, and the Tiara (Tiara), for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe. The Company operates through one business segment: the development, manufacturing and marketing of medical devices. The Company's subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc. The Company carries its business in Canada, the United States and Europe.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

23-04-11	Shockwave Medical Completes Acquisition of Neovasc	MT
23-04-11	ShockWave Medical Closes Neovasc Acquisition; Shares Rise	MT
23-04-11	Traders Cautious as Inflation Data, Fed Minutes Loom, Stifling US Equity Futures	MT
23-04-11	Neovasc Inc.(NasdaqCM:NVCN) dropped from NASDAQ Composite Index	CI
23-04-10	ShockWave Medical, Inc. completed the acquisition of Neovasc Inc. from Strul Medical Group LLC and others.	CI
23-03-31	Neovasc Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-03-31	Neovasc 2022 Loss Widens Ahead of Sale to Shockwave Medical	MT
23-03-30	Neovasc Inc. Auditor Raises 'Going Concern' Doubt	CI
23-03-07	Neovasc Shareholders Approve Proposed Takeover by Shockwave Medical	MT
23-02-01	Neovasc Announced German Reimbursement Renewal	MT
23-01-18	HC Wainwright Downgrades Neovasc to Neutral From Buy	MT
23-01-17	Top Midday Gainers	MT
23-01-17	TSX hits one-month high as domestic inflation eases	RE

23-04-12	Neovasc : Notice of Change in Corporate Structure - Form 6-K	PU
23-04-03	Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update	AQ
23-03-31	Neovasc: Q4 Earnings Snapshot	AQ
23-03-31	Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update	GL
23-03-06	Neovasc : Shareholders Approve Acquisition by Shockwave Medical	PU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NEOVASC INC.	+1.66%	-.--%	-	-	82.83M
THERMO FISHER SCIENTIFIC, INC.	-1.67%	-1.95%	+27.63%	+10.98%	229B
DANAHER CORPORATION	-2.24%	-2.16%	+5.81%	-20.54%	148B
INTUITIVE SURGICAL, INC.	-0.44%	+0.75%	-16.17%	+19.14%	131B
BOSTON SCIENTIFIC CORPORATION	+0.70%	+0.60%	-56.34%	-12.44%	68.04B
EDWARDS LIFESCIENCES CORPORATION	-0.55%	-0.19%	+10.54%	+17.54%	51.75B
SIEMENS HEALTHINEERS AG	+0.95%	-0.96%	-16.97%	-14.11%	50.21B
AGILENT TECHNOLOGIES, INC.	-1.29%	-4.89%	+19.77%	+23.03%	42.28B
WATERS CORPORATION	-1.88%	-1.83%	+42.58%	+47.16%	40.63B
RESMED, INC.	-1.23%	-2.79%	-14.87%	+43.97%	33.06B
Average	-0.43%	-1.35%	+0.22%	+12.75%	88.18B
Weighted average by Cap.	-0.89%	-1.78%	+3.78%	+7.13%

Neovasc Inc. Stock Nasdaq

Stocks

NVCN

CA64065J4037

Advanced Medical Equipment & Technology

Latest news : Neovasc Inc.

Analysts' recommendations : Neovasc Inc.

Press Releases : Neovasc Inc.

Quotes and Performance

Other Advanced Medical Equipment & Technology

Company Profile